AUS
NZ
UK
CA
USA
IND
Highlights
Compumedics announces a new deal with Hangzhou Normal University for its Orion LifeSpan MEG system.
The agreement adds to previous installations, expanding the company’s reach in China’s neuroimaging field.
The order includes advanced neuroimaging software and technology aimed at supporting pediatric and multi-subject studies.
The medical device sector continues to witness rapid advancements, especially in brain imaging technology. Compumedics Limited (ASX:CMP), an established name in neurodiagnostic solutions, has announced a new order for its Neuroscan Orion LifeSpan MEG system from Hangzhou Normal University. This development adds to the company’s growing presence in the region’s advanced neuroscience research field.
Expansion Through Strategic Collaborations
This marks the latest in a series of installations of the Orion LifeSpan MEG system across major Chinese institutions. Previous deployments include Tianjin Normal University, Tsinghua University, and Tianjin University. These collaborations highlight ongoing interest in high-precision neuroimaging platforms capable of meeting both clinical and research needs.
The new order with Hangzhou Normal University includes not only the MEG system itself but also Compumedics' proprietary CURRY neuroimaging software and complementary equipment. Delivery is scheduled to take place in phases, with installation expected to begin within the next couple of years.
Pioneering Features of the Orion LifeSpan System
The Orion LifeSpan MEG system integrates double relaxation oscillation superconducting quantum interference devices (DROS SQUIDs), offering superior sensitivity in detecting brain activity. It is equipped with a dual-helmet dewar that facilitates scanning for both adult and pediatric subjects, enhancing its usability across diverse populations.
Another key feature is the system’s hyperscanning capability, which allows simultaneous recording from multiple individuals. This is particularly valuable for studying social interactions and developmental neuroscience. The advanced cooling mechanism further ensures that the system can operate consistently without frequent service interruptions.
Strengthening Market Position in Asia
This latest partnership underscores Compumedics' evolving status as a preferred supplier of cutting-edge neuroimaging tools within China. The emphasis on research applications, especially in pediatric and developmental studies, aligns with the broader national objectives to enhance neurological health infrastructure.
David Burton, executive chairman of Compumedics, acknowledged China’s role in embracing advanced technologies early in their lifecycle. The sustained interest from academic and clinical institutions in the region points to a robust market for future collaborations.
Vision for Broader Global Engagement
In addition to expanding within China, Compumedics is actively working to increase its reach beyond Asia. Plans are underway to broaden engagement in North America, further supporting the company’s focus on high-tech neuroscience solutions.
The inclusion of Healthcare stocks, ASX 200 like Compumedics (ASX:CMP) in discussions around innovation underscores the strategic importance of neuroimaging in healthcare system advancements. This aligns with broader trends emphasizing the integration of technology and healthcare research in the sector.
Future-Ready Technology for Next-Gen Brain Research
The dual-helmet design of the MEG system and its capacity for continuous operation without major maintenance intervals highlight Compumedics’ commitment to providing reliable, long-term solutions for neurological diagnostics. Its systems are particularly relevant for pediatric neurology, a field that demands precision and adaptability in imaging technology.
Compumedics continues to support global research with scalable tools that align with emerging demands in brain health and diagnostics. With strategic expansions and technological innovations, the company reinforces its standing in the field of advanced neuroimaging solutions.
